Record overview
Status and phase
Status: NOT_YET_RECRUITING
Phase: PHASE1, PHASE2
Sponsor: Sun Yat-sen University
Condition: Bladder Cancer, Muscle-invasive Bladder Cancer
NCT06957561
Disitamab Vedotin Combined With Ivonescimab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: None
Stopped reason
Context when available
No stop reason available in the current public record.